Your browser doesn't support javascript.
loading
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Davis, Angharad G; Wasserman, Sean; Stek, Cari; Maxebengula, Mpumi; Jason Liang, C; Stegmann, Stephani; Koekemoer, Sonya; Jackson, Amanda; Kadernani, Yakub; Bremer, Marise; Daroowala, Remy; Aziz, Saalikha; Goliath, Rene; Lai Sai, Louise; Sihoyiya, Thandi; Denti, Paolo; Lai, Rachel P J; Crede, Thomas; Naude, Jonathan; Szymanski, Patryk; Vallie, Yakoob; Banderker, Ismail Abbas; Moosa, Muhammed S; Raubenheimer, Peter; Candy, Sally; Offiah, Curtis; Wahl, Gerda; Vorster, Isak; Maartens, Gary; Black, John; Meintjes, Graeme; Wilkinson, Robert J.
  • Davis AG; Francis Crick Institute, London, United Kingdom.
  • Wasserman S; Faculty of Life Sciences, University College London, London, United Kingdom.
  • Stek C; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Maxebengula M; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Jason Liang C; Department of Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Stegmann S; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Koekemoer S; Department of Infectious Diseases, Imperial College London, London, United Kingdom.
  • Jackson A; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Kadernani Y; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Bremer M; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Daroowala R; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Aziz S; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Goliath R; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Lai Sai L; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Sihoyiya T; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Denti P; Department of Infectious Diseases, Imperial College London, London, United Kingdom.
  • Lai RPJ; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Crede T; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Naude J; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Szymanski P; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Vallie Y; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Banderker IA; Francis Crick Institute, London, United Kingdom.
  • Moosa MS; Department of Infectious Diseases, Imperial College London, London, United Kingdom.
  • Raubenheimer P; Department of Medicine, Mitchells Plain Hospital, Cape Town, South Africa.
  • Candy S; Department of Medicine, Mitchells Plain Hospital, Cape Town, South Africa.
  • Offiah C; Department of Medicine, Mitchells Plain Hospital, Cape Town, South Africa.
  • Wahl G; Department of Medicine, New Somerset Hospital, Cape Town, South Africa.
  • Vorster I; Department of Medicine, Mitchells Plain Hospital, Cape Town, South Africa.
  • Maartens G; Department of Medicine, New Somerset Hospital, Cape Town, South Africa.
  • Black J; Department of Medicine, University of Cape Town, Observatory, Republic of South Africa.
  • Meintjes G; Division of Diagnostic Radiology, University of Cape Town, Groote Schuur Hospital, Observatory, Republic of South Africa.
  • Wilkinson RJ; Department of Neuroradiology, Imaging Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Clin Infect Dis ; 76(8): 1412-1422, 2023 04 17.
Article en En | MEDLINE | ID: mdl-36482216
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Meníngea / Infecciones por VIH Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Meníngea / Infecciones por VIH Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article